NO20055601L - Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer - Google Patents

Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer

Info

Publication number
NO20055601L
NO20055601L NO20055601A NO20055601A NO20055601L NO 20055601 L NO20055601 L NO 20055601L NO 20055601 A NO20055601 A NO 20055601A NO 20055601 A NO20055601 A NO 20055601A NO 20055601 L NO20055601 L NO 20055601L
Authority
NO
Norway
Prior art keywords
hydrogel
active ingredients
pharmaceutical preparation
transdermal administration
active ingredient
Prior art date
Application number
NO20055601A
Other languages
English (en)
Other versions
NO20055601D0 (no
Inventor
Patrick Franke
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33395772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055601(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20055601D0 publication Critical patent/NO20055601D0/no
Publication of NO20055601L publication Critical patent/NO20055601L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Abstract

Farmasøytisk preparat i form av en hydrogel omfattende karboksylsyreester, C-C-alkylalkohol, virkestoff og polymermatriks. Det beskrives også anvendelse av en karboksylsyreester som transdermalt permeeringsmiddel for et virkestoff i et farmasøytisk preparat i form av en hydrogel, hvor preparatet omfatter en polymermatriks Og C-C-alkylalkohol. Videre beskrives et svettebestandig preparat i form av en hydrogel omfattende en akrylsyre kombinert med et cellulosederivat.
NO20055601A 2003-04-28 2005-11-25 Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer NO20055601L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03008856 2003-04-28
PCT/EP2004/004224 WO2004096191A1 (de) 2003-04-28 2004-04-21 Pharmazeutische zusammensetzung in form eines hydrogels zur transdermalen verabreichung von wirkstoffen

Publications (2)

Publication Number Publication Date
NO20055601D0 NO20055601D0 (no) 2005-11-25
NO20055601L true NO20055601L (no) 2006-01-26

Family

ID=33395772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055601A NO20055601L (no) 2003-04-28 2005-11-25 Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer

Country Status (33)

Country Link
EP (2) EP1875905B1 (no)
JP (2) JP4829102B2 (no)
KR (1) KR101093999B1 (no)
CN (1) CN1780610B (no)
AR (1) AR044113A1 (no)
AT (2) ATE385786T1 (no)
AU (1) AU2004233572B2 (no)
BR (1) BRPI0409918A (no)
CA (1) CA2523734C (no)
CL (1) CL2004000884A1 (no)
CO (1) CO5640075A2 (no)
CR (1) CR8059A (no)
CY (1) CY1108069T1 (no)
DE (2) DE502004011164D1 (no)
DK (1) DK1617827T3 (no)
EA (1) EA008686B1 (no)
EC (1) ECSP056186A (no)
ES (2) ES2345458T3 (no)
HK (1) HK1087633A1 (no)
HR (1) HRP20080178T3 (no)
JO (1) JO2492B1 (no)
MX (1) MXPA05011541A (no)
NO (1) NO20055601L (no)
NZ (2) NZ543264A (no)
PE (1) PE20050461A1 (no)
PL (1) PL1617827T3 (no)
PT (1) PT1617827E (no)
RS (1) RS51307B (no)
SI (1) SI1617827T1 (no)
TW (1) TWI343259B (no)
UA (1) UA83036C2 (no)
WO (1) WO2004096191A1 (no)
ZA (1) ZA200509549B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506141D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A topical compostion and its uses
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
DE102005035879A1 (de) * 2005-07-30 2007-02-01 Paul Hartmann Ag Hydrogel
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
JP5934781B2 (ja) * 2011-04-25 2016-06-15 パーク、ジュン−ヒョン 脱毛防止及び発毛促進用外用剤組成物
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9855211B2 (en) * 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
DE102018213754A1 (de) * 2018-08-15 2020-02-20 Henkel Ag & Co. Kgaa "Tris(hydroxymethyl-)aminomethan oder seine Salze als Wirkstoff zur Reduzierung der Schweißsekretion“

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
DE1182229B (de) 1960-11-16 1964-11-26 Upjohn Co Verfahren zur Herstellung von 7-Methylsteroiden
US3924004A (en) 1971-11-24 1975-12-02 Syntex Corp Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
US4000273A (en) 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
JPS5540604A (en) * 1978-09-14 1980-03-22 Mitsui Toatsu Chem Inc Improved local topicum
FR2518879A1 (fr) * 1981-12-30 1983-07-01 Besins Jean Medicament a base d'oestradiol pour le traitement de la pathologie menopausique
JPS5970612A (ja) 1982-10-13 1984-04-21 Nippon Redarii Kk ゲル軟膏基剤
JPH01503281A (ja) * 1987-05-27 1989-11-09 ブルグハルト，クルト 経皮治療に有効な医薬包帯剤およびこれを施用するためのデバイス
WO1990004397A1 (de) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
JPH08501529A (ja) * 1992-06-11 1996-02-20 セラテック・インコーポレイテッド 皮膚透過薬剤投与緩和のグリセリン使用
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
AU3723695A (en) 1994-09-14 1996-03-29 Minnesota Mining And Manufacturing Company Transdermal device for delivery of levonorgestrel
FR2732223B1 (fr) 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
DE19526864A1 (de) 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
JPH09194396A (ja) 1996-01-17 1997-07-29 Pola Chem Ind Inc 貼付剤用マトリックス
US5733565A (en) 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
US5736128A (en) * 1996-05-14 1998-04-07 Isp Investments Inc. Cosmetic composition for rejuvenation of skin without skin irritation
EP0954260A1 (en) 1996-05-22 1999-11-10 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
IT1283102B1 (it) * 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
US5993787A (en) 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
ID27260A (id) 1998-06-19 2001-03-22 Akzo Nobel Nv Turunan testosteron
FR2781666B1 (fr) * 1998-07-30 2000-09-08 Oreal Composition cosmetique solide et ses utilisations
JP2935113B1 (ja) * 1998-09-24 1999-08-16 小林製薬株式会社 インドメタシン経皮吸収剤
WO2000041702A1 (fr) 1999-01-13 2000-07-20 Taisho Pharmaceutical Co., Ltd. Preparation steroide externe
JP2000264899A (ja) * 1999-01-13 2000-09-26 Taisho Pharmaceut Co Ltd ステロイド外用剤
JP2001139451A (ja) * 1999-11-17 2001-05-22 Lion Corp ジェル状化粧料
AU2002229663A1 (en) 2000-12-15 2002-06-24 Akzo Nobel N.V. 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational activity profile
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
DE10107663B4 (de) 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
EP1875905B1 (de) 2010-05-12
CR8059A (es) 2006-05-29
CN1780610A (zh) 2006-05-31
JP2010241824A (ja) 2010-10-28
EP1617827A1 (de) 2006-01-25
CO5640075A2 (es) 2006-05-31
WO2004096191A1 (de) 2004-11-11
NO20055601D0 (no) 2005-11-25
EA200501583A1 (ru) 2006-06-30
HRP20080178T3 (en) 2008-05-31
JP2006524653A (ja) 2006-11-02
CA2523734A1 (en) 2004-11-11
NZ543264A (en) 2010-03-26
ECSP056186A (es) 2006-04-19
KR20060007403A (ko) 2006-01-24
AU2004233572B2 (en) 2010-07-15
DK1617827T3 (da) 2008-06-02
RS51307B (sr) 2010-12-31
AU2004233572A1 (en) 2004-11-11
DE502004011164D1 (de) 2010-06-24
CA2523734C (en) 2009-12-22
TW200524644A (en) 2005-08-01
CN1780610B (zh) 2010-06-09
CY1108069T1 (el) 2014-02-12
CL2004000884A1 (es) 2005-03-11
BRPI0409918A (pt) 2006-04-25
RS20050809A (en) 2007-09-21
JO2492B1 (en) 2009-10-05
NZ583760A (en) 2011-10-28
KR101093999B1 (ko) 2011-12-15
PL1617827T3 (pl) 2008-07-31
PE20050461A1 (es) 2005-08-13
HK1087633A1 (en) 2006-10-20
EP1875905A2 (de) 2008-01-09
PT1617827E (pt) 2008-04-30
EP1617827B1 (de) 2008-02-13
AR044113A1 (es) 2005-08-24
ATE385786T1 (de) 2008-03-15
MXPA05011541A (es) 2006-05-31
JP4829102B2 (ja) 2011-12-07
EP1875905A3 (de) 2008-06-25
ES2300763T3 (es) 2008-06-16
TWI343259B (en) 2011-06-11
DE502004006196D1 (de) 2008-03-27
ZA200509549B (en) 2007-02-28
EA008686B1 (ru) 2007-06-29
ATE467412T1 (de) 2010-05-15
ES2345458T3 (es) 2010-09-23
UA83036C2 (ru) 2008-06-10
SI1617827T1 (sl) 2008-06-30

Similar Documents

Publication Publication Date Title
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
US9675562B2 (en) Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20050187212A1 (en) Pharmaceutical composition for topical delivery of meloxicam
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
TW200815045A (en) Pharmaceutical compositions of ropinirole and methods of use thereof
BRPI0508933A (pt) composições para entrega tópica
DE60313359D1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
EP2654638A1 (en) Composition for transdermal administration of non-steroidal anti-inflammatory drug
NO20073457L (no) Stabile sammensetninger av fenofibrat med fettsyreestere
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
DE60232271D1 (de) Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol-verbindungen
DK1305057T3 (da) Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse
KR101490708B1 (ko) 록소프로펜 또는 그의 염을 포함하는 경피 흡수용 조성물및 이를 포함하는 경피 투여 첩부제
BRPI0506710A (pt) composições farmacêuticas de liberação controlada
KR20110053236A (ko) 경피 투여용 조성물
AU2003264113A1 (en) Composition and use thereof as a pharmaceutical or cosmetic formulation for external application
TH69376A (th) สารผสมทางเภสัชกรรมในรูปของเจลน้ำสำหรับการให้ส่วนผสมที่มีฤทธิ์ต่างๆ ผ่านผิวหนัง
DK1691805T3 (da) Anvendelse af urocansyre som er i stand til at omdanne celle cytoplasm til syre
AR045973A1 (es) Composiciones de liberacion controlada y sus metodos de fabricacion
UA84678C2 (ru) Фармацевтической композиции модифицированного высвобождения соли производного манделовой кислоты и ее применение для лечения сердечнососудистых нарушений

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application